China-based AK Medical expanded its 3D printing capacity by investing in eight GE Arcam EMB 3D printers to address the increasing orthopedic demands of China’s aging population. AK Medical’s 3D-printed portfolio includes hip implants, spinal interbody cages and artificial vertebral bodies. In 2019, these products generated revenues of RMB 123.4 million (USD $17.4 million), growth of +76.5% compared to the prior year.
Li Zhijiang, Chairman, CEO and Executive Director of AK Medical, said, “Additive technology itself is tremendously advantageous in terms of cost, and personalized customization is increasingly becoming an industry trend. When you begin to think of it in combination with CT, nuclear MRI, software, the Internet, 5G and many other technologies, then AM is likely to unleash greater potential to boost the entire medical industry.”
China-based AK Medical expanded its 3D printing capacity by investing in eight GE Arcam EMB 3D printers to address the increasing orthopedic demands of China's aging population. AK Medical's 3D-printed portfolio includes hip implants, spinal interbody cages and artificial vertebral bodies. In 2019, these products generated revenues of RMB...
China-based AK Medical expanded its 3D printing capacity by investing in eight GE Arcam EMB 3D printers to address the increasing orthopedic demands of China’s aging population. AK Medical’s 3D-printed portfolio includes hip implants, spinal interbody cages and artificial vertebral bodies. In 2019, these products generated revenues of RMB 123.4 million (USD $17.4 million), growth of +76.5% compared to the prior year.
Li Zhijiang, Chairman, CEO and Executive Director of AK Medical, said, “Additive technology itself is tremendously advantageous in terms of cost, and personalized customization is increasingly becoming an industry trend. When you begin to think of it in combination with CT, nuclear MRI, software, the Internet, 5G and many other technologies, then AM is likely to unleash greater potential to boost the entire medical industry.”
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.
Copy to clipboard 
